Biovica (Q1 review): Funded for strategy - Redeye
Bildkälla: Stockfoto

Biovica (Q1 review): Funded for strategy - Redeye

Redeye returns with a research update after Biovica's Q1 2026/2027 report, which came in a bit below our expectations, but most notably laid the foundation for the continued turnaround with CEO Theis Kipling at the helm.

Redeye returns with a research update after Biovica's Q1 2026/2027 report, which came in a bit below our expectations, but most notably laid the foundation for the continued turnaround with CEO Theis Kipling at the helm.
Börsvärldens nyhetsbrev